Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Withdrawn Phase 2 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0029236 (Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01652014Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesTreatment